Back to today’s briefing

Story perspectives

Psilocybin Research Sparks Hope for Postpartum Depression Treatment

11/1/2025

39 3

Summary

Story summary

Researchers at the University of South Florida study psilocybin as a treatment for postpartum depression and major depressive disorders.
Dr. Ryan Wagoner says psilocybin could gain FDA approval if its benefits outweigh risks.
Tracey Tee, founder of Moms on Mushrooms, advocates microdosing as a viable option but says it should supplement other treatments.
Florida still bans psilocybin, listing it as a Schedule 1 controlled substance.

1 of 1

Story summary

Researchers at the University of South Florida study psilocybin as a treatment for postpartum depression and major depressive disorders.
Dr. Ryan Wagoner says psilocybin could gain FDA approval if its benefits outweigh risks.
Tracey Tee, founder of Moms on Mushrooms, advocates microdosing as a viable option but says it should supplement other treatments.
Florida still bans psilocybin, listing it as a Schedule 1 controlled substance.